<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01490580</url>
  </required_header>
  <id_info>
    <org_study_id>PRETTINEO</org_study_id>
    <nct_id>NCT01490580</nct_id>
  </id_info>
  <brief_title>Premedication Trial for Tracheal Intubation of the NEOnate</brief_title>
  <acronym>PRETTINEO</acronym>
  <official_title>Double Blind Randomized Controlled Trial Comparing &quot;Atropine+Propofol&quot; Versus &quot;Atropine+Atracurium+Sufentanil&quot; as a Premedication Prior to Semi-urgent or Elective Endotracheal Intubation of Term and Preterm Newborns</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Intercommunal Creteil</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Association Clinique Thérapeutique Infantile du val de Marne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CRC (Centre de Recherche Clinique) du CHIC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Intercommunal Creteil</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multicenter double blind randomized controlled trial comparing &quot;atropine+propofol&quot; vs
      &quot;atropine+atracurium+sufentanil&quot; as a premedication prior to endotracheal intubation of the
      neonate.

      Primary outcome: pulse oxymetry value &lt; 80% for more than 60 seconds. Secondary outcomes:
      number of attempts, duration of the procedure, changes in physiologic parameters, short- and
      long-term neurodevelopmental outcome.

      Hypothesis: &quot;atropine + propofol&quot; compared to &quot;atropine+atracurium+sufentanil&quot; will
      significantly reduce the frequency of severe hypoxemia.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 2012</start_date>
  <completion_date type="Anticipated">April 2020</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Patients With Prolonged Desaturation</measure>
    <time_frame>During intubation procedure, expected duration 1 to 15 minutes</time_frame>
    <description>Pulse oxymetry value measured by Masimo technology below 80% for 60 seconds or more.
Duration of intubation is defined by the time between first laryngoscope insertion and last laryngoscope removal after successful intubation. Successful intubation is defined by clear bilateral breath sounds, increasing heart rate and saturation (if previously low) and appropriate flow curves on the ventilator.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Intubation Attempts</measure>
    <time_frame>During intubation procedure, expected duration 1 to 15 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Intubation Procedure</measure>
    <time_frame>Expected duration 1 to 15 minutes</time_frame>
    <description>Although the initial definition of procedure duration in the registered protocol was the time between the first laryngoscope insertion and last laryngoscope removal after successful intubation, the variable collected in the clinical research form was defined as the time between first laryngoscope insertion and the fixation of the tube with tape.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate</measure>
    <time_frame>from 1 minute before to 60 minutes after the start of premedication</time_frame>
    <description>Heart rate recordings 1 minute before the first injection and at 3, 6, 9, 12, 15, 30, 45 and 60 minutes after the first injection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short Term Neurological Outcome: Worsening of Head Ultrasound</measure>
    <time_frame>Within 7 days after inclusion</time_frame>
    <description>Worsening of head ultrasound scans in the 7 days after intubation from the preinclusion evaluation, defined as either a normal scan before inclusion and any grade intraventricular hemorrhage (IVH) afterwards, or as a preinclusion grade 1 or 2 IVH scan deteriorating to grade 3 or 4 IVH, according to Papile's classification; This analysis was not centralized but performed in each center according to its usual protocols.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Long Term Neurodevelopmental Outcome</measure>
    <time_frame>At 2 years corrected age</time_frame>
    <description>Age and stages questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulse Oxymetry</measure>
    <time_frame>from 1 minute before to 60 minutes after the start of premedication</time_frame>
    <description>Pulse oxymetry recordings 1 minute before the first injection and at 3, 6, 9, 12, 15, 30, 45 and 60 minutes after the first injection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Blood Pressure</measure>
    <time_frame>from 1 minute before to 60 minutes after the start of premedication</time_frame>
    <description>Blood pressure recordings 1 minute before the first injection and at 3, 6, 9, 12, 15, 30, 45 and 60 minutes after the first injection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transcutaneous PCO2 (TcPCO2) Measurement</measure>
    <time_frame>from 1 minute before to 60 minutes after the start of premedication</time_frame>
    <description>TcPCO2 recordings 1 minute before the first injection and at 3, 6, 9, 12, 15, 30, 45 and 60 minutes after the first injection</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">173</enrollment>
  <condition>Premedication</condition>
  <condition>Endotracheal Intubation</condition>
  <arm_group>
    <arm_group_label>Atropine + Propofol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Atropine + atracurium + sufentanil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>atropine+ propofol</intervention_name>
    <description>Atropine bolus: 20 µg/kg Propofol injected over 60 seconds: 1 mg/kg for infants &lt; 1000g - Renewable once 2.5 mg/kg for infants &gt; 1000G - Possible additional dose of 1 mg/kg</description>
    <arm_group_label>Atropine + Propofol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>atropine + atracurium + sufentanil</intervention_name>
    <description>Atropine bolus: 20 µg/kg Atracurium: 0.3 mg/kg- Possible additional dose of 0.1 mg/kg Sufentanil: 0.1 µg/kg for infants &lt; 1000g 0.2 µg/kg for infants &gt; 1000g</description>
    <arm_group_label>Atropine + atracurium + sufentanil</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Corrected age &lt; 45 weeks of gestational age

          -  Currently hospitalized in a neonatal intensive care unit

          -  Requiring semi-urgent or elective intubation

          -  Equipped with a reliable and permeable IV line

          -  Parental consent

        Exclusion Criteria:

          -  Lack of parental consent

          -  Parental refusal

          -  Sedative or anesthetic treatment in the previous 24 hours

          -  Hemodynamic compromise defined as mean blood pressure&lt; corrected GA and/or refill time
             &gt; 3 seconds

          -  Upper airway malformation

          -  Life-threatening situation requiring immediate intubation

          -  Inclusion in another trial not permitting any other participation

          -  Impossibility to establish venous access

          -  Any contra-indication to any experimental drug
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>28 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xavier Durrmeyer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHI Creteil</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Médecine Néonatale et Réanimation Pédiatrique Polyvalente, CHU Amiens Nord</name>
      <address>
        <city>Amiens</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Mère-Enfant</name>
      <address>
        <city>Bron</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Caen</name>
      <address>
        <city>Caen</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Intercommunal de Créteil</name>
      <address>
        <city>Créteil</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital des Enfants</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Réanimation Pédiatrique et Néonatale de l'hôpital Clochevile, Centre Hospitalier Universitaire de Tours</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Durrmeyer X, Breinig S, Claris O, Tourneux P, Alexandre C, Saliba E, Beuchée A, Jung C, Levy C, Marchand-Martin L, Marcoux MO, Dechartres A, Danan C; PRETTINEO Research Group. Effect of Atropine With Propofol vs Atropine With Atracurium and Sufentanil on Oxygen Desaturation in Neonates Requiring Nonemergency Intubation: A Randomized Clinical Trial. JAMA. 2018 May 1;319(17):1790-1801. doi: 10.1001/jama.2018.3708.</citation>
    <PMID>29715354</PMID>
  </results_reference>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>December 8, 2011</study_first_submitted>
  <study_first_submitted_qc>December 9, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 13, 2011</study_first_posted>
  <results_first_submitted>July 16, 2018</results_first_submitted>
  <results_first_submitted_qc>August 8, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">September 13, 2019</results_first_posted>
  <last_update_submitted>August 8, 2019</last_update_submitted>
  <last_update_submitted_qc>August 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Intercommunal Creteil</investigator_affiliation>
    <investigator_full_name>Xavier Durrmeyer</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Pain</keyword>
  <keyword>Newborn</keyword>
  <keyword>Anaesthesia</keyword>
  <keyword>opioids</keyword>
  <keyword>propofol</keyword>
  <keyword>neuromuscular blocker</keyword>
  <keyword>atropine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atropine</mesh_term>
    <mesh_term>Sufentanil</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Atracurium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The trial was prematurely interrupted for logistic reasons in July 2016: a fourth drug manufacturing run was necessary because the intralipids had passed their expiration date and funding had run out. During the study period, 755 patients were screened for eligibility, and 173 randomized</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Atropine Atracurium Sufentanil</title>
          <description>n=82 allocated to atropine+atracurium+sufentanil
n=80 received allocated intervention
n=2 did not receive allocated intervention
n=1 never intubated
n=1 received another premedication
82 included in final analysis</description>
        </group>
        <group group_id="P2">
          <title>Atropine Propofol</title>
          <description>n=91 allocated to atropine+propofol
n= 2 excluded for lack of consent
n=83 received allocated intervention
n=6 did not receive allocated intervention
n=2 never intubated
n=4 received another premedication
89 included in final analysis</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="82"/>
                <participants group_id="P2" count="91"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="82"/>
                <participants group_id="P2" count="89"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Parents withdrew consent</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Atropine Atracurium Sufentanil</title>
        </group>
        <group group_id="B2">
          <title>Atropine Propofol</title>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="82"/>
            <count group_id="B2" value="89"/>
            <count group_id="B3" value="171"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="82"/>
                    <count group_id="B2" value="89"/>
                    <count group_id="B3" value="171"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="82"/>
                    <measurement group_id="B2" value="89"/>
                    <measurement group_id="B3" value="171"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="82"/>
                    <count group_id="B2" value="89"/>
                    <count group_id="B3" value="171"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1" lower_limit="0" upper_limit="10"/>
                    <measurement group_id="B2" value="1" lower_limit="0" upper_limit="9"/>
                    <measurement group_id="B3" value="1" lower_limit="0" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="82"/>
                    <count group_id="B2" value="89"/>
                    <count group_id="B3" value="171"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="45"/>
                    <measurement group_id="B3" value="70"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="57"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="101"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>France</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="82"/>
                    <count group_id="B2" value="89"/>
                    <count group_id="B3" value="171"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="82"/>
                    <measurement group_id="B2" value="89"/>
                    <measurement group_id="B3" value="171"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Median GA at birth [IQR], weeks</title>
          <units>WEEKS</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="82"/>
                    <count group_id="B2" value="89"/>
                    <count group_id="B3" value="171"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29" lower_limit="26" upper_limit="32"/>
                    <measurement group_id="B2" value="30" lower_limit="28" upper_limit="34"/>
                    <measurement group_id="B3" value="29" lower_limit="27" upper_limit="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Median birth weight [IQR], g</title>
          <units>GRAMS</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="82"/>
                    <count group_id="B2" value="89"/>
                    <count group_id="B3" value="171"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1130" lower_limit="850" upper_limit="1685"/>
                    <measurement group_id="B2" value="1310" lower_limit="815" upper_limit="2385"/>
                    <measurement group_id="B3" value="1190" lower_limit="830" upper_limit="2020"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Reason for intubation, n (%)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="82"/>
                    <count group_id="B2" value="89"/>
                    <count group_id="B3" value="171"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Respiratory distress syndrome</title>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                    <measurement group_id="B2" value="60"/>
                    <measurement group_id="B3" value="110"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Apnea</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Surgery</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="36"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Patients With Prolonged Desaturation</title>
        <description>Pulse oxymetry value measured by Masimo technology below 80% for 60 seconds or more.
Duration of intubation is defined by the time between first laryngoscope insertion and last laryngoscope removal after successful intubation. Successful intubation is defined by clear bilateral breath sounds, increasing heart rate and saturation (if previously low) and appropriate flow curves on the ventilator.</description>
        <time_frame>During intubation procedure, expected duration 1 to 15 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Atropine Atracurium Sufentanil</title>
          </group>
          <group group_id="O2">
            <title>Atropine Propofol</title>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With Prolonged Desaturation</title>
          <description>Pulse oxymetry value measured by Masimo technology below 80% for 60 seconds or more.
Duration of intubation is defined by the time between first laryngoscope insertion and last laryngoscope removal after successful intubation. Successful intubation is defined by clear bilateral breath sounds, increasing heart rate and saturation (if previously low) and appropriate flow curves on the ventilator.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54"/>
                    <measurement group_id="O2" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.38</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>-6.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-21.0</ci_lower_limit>
            <ci_upper_limit>8.1</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Intubation Attempts</title>
        <time_frame>During intubation procedure, expected duration 1 to 15 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Atropine + Propofol</title>
            <description>atropine+ propofol: Atropine bolus: 20 µg/kg Propofol injected over 60 seconds: 1 mg/kg for infants &lt; 1000g - Renewable once 2.5 mg/kg for infants &gt; 1000G - Possible additional dose of 1 mg/kg</description>
          </group>
          <group group_id="O2">
            <title>Atropine + Atracurium + Sufentanil</title>
            <description>atropine + atracurium + sufentanil: Atropine bolus: 20 µg/kg Atracurium: 0.3 mg/kg- Possible additional dose of 0.1 mg/kg Sufentanil: 0.1 µg/kg for infants &lt; 1000g 0.2 µg/kg for infants &gt; 1000g</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Intubation Attempts</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="89"/>
                <count group_id="O2" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>1 attempt</title>
                  <measurement_list>
                    <measurement group_id="O1" value="41"/>
                    <measurement group_id="O2" value="47"/>
                  </measurement_list>
                </category>
                <category>
                  <title>2 attempts</title>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt; 2 attempts</title>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Missing data</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Duration of Intubation Procedure</title>
        <description>Although the initial definition of procedure duration in the registered protocol was the time between the first laryngoscope insertion and last laryngoscope removal after successful intubation, the variable collected in the clinical research form was defined as the time between first laryngoscope insertion and the fixation of the tube with tape.</description>
        <time_frame>Expected duration 1 to 15 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Atropine + Propofol</title>
            <description>atropine+ propofol: Atropine bolus: 20 µg/kg Propofol injected over 60 seconds: 1 mg/kg for infants &lt; 1000g - Renewable once 2.5 mg/kg for infants &gt; 1000G - Possible additional dose of 1 mg/kg</description>
          </group>
          <group group_id="O2">
            <title>Atropine + Atracurium + Sufentanil</title>
            <description>atropine + atracurium + sufentanil: Atropine bolus: 20 µg/kg Atracurium: 0.3 mg/kg- Possible additional dose of 0.1 mg/kg Sufentanil: 0.1 µg/kg for infants &lt; 1000g 0.2 µg/kg for infants &gt; 1000g</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of Intubation Procedure</title>
          <description>Although the initial definition of procedure duration in the registered protocol was the time between the first laryngoscope insertion and last laryngoscope removal after successful intubation, the variable collected in the clinical research form was defined as the time between first laryngoscope insertion and the fixation of the tube with tape.</description>
          <units>Minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="80"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.0" lower_limit="2.8" upper_limit="9.1"/>
                    <measurement group_id="O2" value="3.5" lower_limit="1.3" upper_limit="6.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Heart Rate</title>
        <description>Heart rate recordings 1 minute before the first injection and at 3, 6, 9, 12, 15, 30, 45 and 60 minutes after the first injection</description>
        <time_frame>from 1 minute before to 60 minutes after the start of premedication</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Atropine + Propofol</title>
            <description>atropine+ propofol: Atropine bolus: 20 µg/kg Propofol injected over 60 seconds: 1 mg/kg for infants &lt; 1000g - Renewable once 2.5 mg/kg for infants &gt; 1000G - Possible additional dose of 1 mg/kg</description>
          </group>
          <group group_id="O2">
            <title>Atropine + Atracurium + Sufentanil</title>
            <description>atropine + atracurium + sufentanil: Atropine bolus: 20 µg/kg Atracurium: 0.3 mg/kg- Possible additional dose of 0.1 mg/kg Sufentanil: 0.1 µg/kg for infants &lt; 1000g 0.2 µg/kg for infants &gt; 1000g</description>
          </group>
        </group_list>
        <measure>
          <title>Heart Rate</title>
          <description>Heart rate recordings 1 minute before the first injection and at 3, 6, 9, 12, 15, 30, 45 and 60 minutes after the first injection</description>
          <units>bpm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="86"/>
                <count group_id="O2" value="80"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Heart rate from t-1 to t+6, Difference in bpm</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3" spread="19.5"/>
                    <measurement group_id="O2" value="11.5" spread="19.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Heart rate from t-1 to t+9, Difference in bpm</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.6" spread="25.2"/>
                    <measurement group_id="O2" value="11.7" spread="25.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Short Term Neurological Outcome: Worsening of Head Ultrasound</title>
        <description>Worsening of head ultrasound scans in the 7 days after intubation from the preinclusion evaluation, defined as either a normal scan before inclusion and any grade intraventricular hemorrhage (IVH) afterwards, or as a preinclusion grade 1 or 2 IVH scan deteriorating to grade 3 or 4 IVH, according to Papile's classification; This analysis was not centralized but performed in each center according to its usual protocols.</description>
        <time_frame>Within 7 days after inclusion</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Atropine + Propofol</title>
            <description>atropine+ propofol: Atropine bolus: 20 µg/kg Propofol injected over 60 seconds: 1 mg/kg for infants &lt; 1000g - Renewable once 2.5 mg/kg for infants &gt; 1000G - Possible additional dose of 1 mg/kg</description>
          </group>
          <group group_id="O2">
            <title>Atropine + Atracurium + Sufentanil</title>
            <description>atropine + atracurium + sufentanil: Atropine bolus: 20 µg/kg Atracurium: 0.3 mg/kg- Possible additional dose of 0.1 mg/kg Sufentanil: 0.1 µg/kg for infants &lt; 1000g 0.2 µg/kg for infants &gt; 1000g</description>
          </group>
        </group_list>
        <measure>
          <title>Short Term Neurological Outcome: Worsening of Head Ultrasound</title>
          <description>Worsening of head ultrasound scans in the 7 days after intubation from the preinclusion evaluation, defined as either a normal scan before inclusion and any grade intraventricular hemorrhage (IVH) afterwards, or as a preinclusion grade 1 or 2 IVH scan deteriorating to grade 3 or 4 IVH, according to Papile's classification; This analysis was not centralized but performed in each center according to its usual protocols.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="68"/>
                <count group_id="O2" value="68"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Long Term Neurodevelopmental Outcome</title>
        <description>Age and stages questionnaire</description>
        <time_frame>At 2 years corrected age</time_frame>
        <posting_date>04/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pulse Oxymetry</title>
        <description>Pulse oxymetry recordings 1 minute before the first injection and at 3, 6, 9, 12, 15, 30, 45 and 60 minutes after the first injection</description>
        <time_frame>from 1 minute before to 60 minutes after the start of premedication</time_frame>
        <population>Changes in SpO2 value from baseline were analyzed at predefined time points. Data was missing at some time points.</population>
        <group_list>
          <group group_id="O1">
            <title>Atropine + Propofol</title>
            <description>atropine+ propofol: Atropine bolus: 20 µg/kg Propofol injected over 60 seconds: 1 mg/kg for infants &lt; 1000g - Renewable once 2.5 mg/kg for infants &gt; 1000G - Possible additional dose of 1 mg/kg</description>
          </group>
          <group group_id="O2">
            <title>Atropine + Atracurium + Sufentanil</title>
            <description>atropine + atracurium + sufentanil: Atropine bolus: 20 µg/kg Atracurium: 0.3 mg/kg- Possible additional dose of 0.1 mg/kg Sufentanil: 0.1 µg/kg for infants &lt; 1000g 0.2 µg/kg for infants &gt; 1000g</description>
          </group>
        </group_list>
        <measure>
          <title>Pulse Oxymetry</title>
          <description>Pulse oxymetry recordings 1 minute before the first injection and at 3, 6, 9, 12, 15, 30, 45 and 60 minutes after the first injection</description>
          <population>Changes in SpO2 value from baseline were analyzed at predefined time points. Data was missing at some time points.</population>
          <units>% SpO2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="85"/>
                <count group_id="O2" value="80"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>SpO2 from t-1 to t+6, Difference in %</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="85"/>
                    <count group_id="O2" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.0" spread="20.1"/>
                    <measurement group_id="O2" value="-12.0" spread="20.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SpO2 from t-1 to t+9, Difference in %</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="84"/>
                    <count group_id="O2" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-8.7" spread="22.3"/>
                    <measurement group_id="O2" value="-15.9" spread="22.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Blood Pressure</title>
        <description>Blood pressure recordings 1 minute before the first injection and at 3, 6, 9, 12, 15, 30, 45 and 60 minutes after the first injection</description>
        <time_frame>from 1 minute before to 60 minutes after the start of premedication</time_frame>
        <population>Changes from baseline in mean arterial blood pressure (MAP) were analyzed at predefined time points. Values were missing at some time points.</population>
        <group_list>
          <group group_id="O1">
            <title>Atropine + Propofol</title>
            <description>atropine+ propofol: Atropine bolus: 20 µg/kg Propofol injected over 60 seconds: 1 mg/kg for infants &lt; 1000g - Renewable once 2.5 mg/kg for infants &gt; 1000G - Possible additional dose of 1 mg/kg</description>
          </group>
          <group group_id="O2">
            <title>Atropine + Atracurium + Sufentanil</title>
            <description>atropine + atracurium + sufentanil: Atropine bolus: 20 µg/kg Atracurium: 0.3 mg/kg- Possible additional dose of 0.1 mg/kg Sufentanil: 0.1 µg/kg for infants &lt; 1000g 0.2 µg/kg for infants &gt; 1000g</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Blood Pressure</title>
          <description>Blood pressure recordings 1 minute before the first injection and at 3, 6, 9, 12, 15, 30, 45 and 60 minutes after the first injection</description>
          <population>Changes from baseline in mean arterial blood pressure (MAP) were analyzed at predefined time points. Values were missing at some time points.</population>
          <units>Difference in mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="80"/>
                <count group_id="O2" value="77"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Mean arterial blood pressure from t-1 to t+15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="80"/>
                    <count group_id="O2" value="77"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.8" spread="12.7"/>
                    <measurement group_id="O2" value="0.2" spread="12.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mean arterial blood pressure from t-1 to t+30</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="76"/>
                    <count group_id="O2" value="74"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-9.1" spread="9.3"/>
                    <measurement group_id="O2" value="-3.3" spread="9.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Transcutaneous PCO2 (TcPCO2) Measurement</title>
        <description>TcPCO2 recordings 1 minute before the first injection and at 3, 6, 9, 12, 15, 30, 45 and 60 minutes after the first injection</description>
        <time_frame>from 1 minute before to 60 minutes after the start of premedication</time_frame>
        <population>Changes in TcPCO2 from baseline were analyzed at predefined time points. Values were missing at some time points.</population>
        <group_list>
          <group group_id="O1">
            <title>Atropine + Propofol</title>
            <description>atropine+ propofol: Atropine bolus: 20 µg/kg Propofol injected over 60 seconds: 1 mg/kg for infants &lt; 1000g - Renewable once 2.5 mg/kg for infants &gt; 1000G - Possible additional dose of 1 mg/kg</description>
          </group>
          <group group_id="O2">
            <title>Atropine + Atracurium + Sufentanil</title>
            <description>atropine + atracurium + sufentanil: Atropine bolus: 20 µg/kg Atracurium: 0.3 mg/kg- Possible additional dose of 0.1 mg/kg Sufentanil: 0.1 µg/kg for infants &lt; 1000g 0.2 µg/kg for infants &gt; 1000g</description>
          </group>
        </group_list>
        <measure>
          <title>Transcutaneous PCO2 (TcPCO2) Measurement</title>
          <description>TcPCO2 recordings 1 minute before the first injection and at 3, 6, 9, 12, 15, 30, 45 and 60 minutes after the first injection</description>
          <population>Changes in TcPCO2 from baseline were analyzed at predefined time points. Values were missing at some time points.</population>
          <units>Difference in mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>TcPCO2 from t-1 to t+15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                    <count group_id="O2" value="29"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.0" spread="14.4"/>
                    <measurement group_id="O2" value="14.1" spread="14.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>TcPCO2 from t-1 to t+30</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="30"/>
                    <count group_id="O2" value="29"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.1" spread="19.1"/>
                    <measurement group_id="O2" value="16.2" spread="19.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Atropine + Propofol</title>
          <description>atropine+ propofol: Atropine bolus: 20 µg/kg Propofol injected over 60 seconds: 1 mg/kg for infants &lt; 1000g - Renewable once 2.5 mg/kg for infants &gt; 1000G - Possible additional dose of 1 mg/kg</description>
        </group>
        <group group_id="E2">
          <title>Atropine + Atracurium + Sufentanil</title>
          <description>atropine + atracurium + sufentanil: Atropine bolus: 20 µg/kg Atracurium: 0.3 mg/kg- Possible additional dose of 0.1 mg/kg Sufentanil: 0.1 µg/kg for infants &lt; 1000g 0.2 µg/kg for infants &gt; 1000g</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="83"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="80"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="83"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="80"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="83"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="80"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>OTHER</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="83"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="80"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="83"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="80"/>
              </event>
              <event>
                <sub_title>Thoracic rigidity</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="83"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="80"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypotension (treated)</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="83"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="80"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="25" subjects_at_risk="83"/>
                <counts group_id="E2" subjects_affected="28" subjects_at_risk="80"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="83"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="80"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Other</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="83"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="80"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypotension, not treated</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="83"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="80"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="83"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="80"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Xavier Durrmeyer</name_or_title>
      <organization>NICU, CHI Créteil</organization>
      <phone>+33145175433</phone>
      <email>xavier.durrmeyer@chicreteil.fr</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

